Related Experiment Video
Updated: Aug 16, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Population-based frequency of dyslipidemia syndromes in coronary-prone families in Utah
R R Williams1, P N Hopkins, S C Hunt
1Department of Medicine, University of Utah, Salt Lake City.
Insights
Familial dyslipidemia syndromes are common in early coronary heart disease (CHD) families. Early recognition and treatment of lipid abnormalities like high cholesterol and low HDL-C are crucial for preventing premature CHD.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Metabolic Disorders
Background:
- Early coronary heart disease (CHD) often has underlying genetic lipid disorders.
- Familial dyslipidemia syndromes are frequently undiagnosed, contributing to premature cardiovascular events.
Purpose of the Study:
- To determine the frequency of familial dyslipidemia syndromes in families with early-onset CHD.
- To identify common lipid abnormalities and genetic syndromes associated with premature CHD.
Main Methods:
- Blood lipid tests were conducted on 33 families with at least two siblings diagnosed with CHD before age 55.
- Prevalence of specific lipid abnormalities (cholesterol, triglycerides, HDL-C) and familial syndromes was calculated.
Main Results:
- Three-fourths of individuals with early CHD exhibited significant lipid abnormalities.
- Familial combined hyperlipidemia and familial dyslipidemic hypertension were the most prevalent syndromes.
- Abnormalities in high-density lipoprotein cholesterol (HDL-C) and triglycerides were more common than low-density lipoprotein cholesterol (LDL-C) issues.
Conclusions:
- Common familial dyslipidemia syndromes are strongly associated with early-onset CHD.
- Physicians must evaluate family history and all lipid parameters to identify and manage these conditions proactively.
- Timely diagnosis and treatment of familial dyslipidemias can mitigate the risk of premature CHD.
Abstract:
The frequency of familial dyslipidemia syndromes was determined from blood tests in 33 objectively ascertained families with early coronary heart disease (CHD) (two or more siblings with CHD by the age of 55 years). Three fourths of persons with early CHD in these families had 90th percentile lipid abnormalities (cholesterol level at or above the 90th percentile, triglyceride level at or above the 90th percentile, and/or high-density lipoprotein cholesterol (HDL-C) level at or less than the 10th percentile). The HDL-C and triglyceride abnormalities were twice as common as low-density lipoprotein-cholesterol abnormalities. The most common syndromes found were familial combined hyperlipidemia (36% to 48% of families with CHD), familial dyslipidemic hypertension (21% to 54% of families with CHD), and isolated low levels of HDL-C (15%), with overlapping familial dyslipidemic hypertension with familial combined hyperlipidemia and low-level HDL-C. Well-defined monogenic syndromes were uncommon: familial hypercholesterolemia being 3% and familial type III hyperlipidemia, 3%. Another 15% of families with CHD had no lipid abnormalities at the 90th percentile. Physicians should learn to recognize and treat these common familial syndromes before the onset of CHD by evaluating family history and all three standard blood lipid determinations. Failure to recognize and treat them leaves affected family members at high risk of premature CHD.
Related Concept Videos
Lipids: Dietary Sources and Requirements
Pharmacogenomics: Identification of New Drug Targets
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management

